Study of Olaparib (Lynparza™) Versus Enzalutamide or Abiraterone Acetate in Men With Metastatic Castration-Resistant Prostate Cancer (PROfound Study)
Clinical trial NCT02987543 · COMPLETED
Trial details
- NCT number
- NCT02987543
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-06
- Primary completion
- 2019-06-04
- Enrollment
- 387
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.